基本信息
浏览量:96
职业迁徙
个人简介
I am an experienced medicinal chemist with success at every stage of drug discovery, from lead identification and lead optimization to candidate recommendation, preclinical development and commercialization. I played a key role in programs that delivered seven clinical candidates. I am a co-inventor of the cholesterol absorption inhibitor ezetimibe, which is now marketed as Zetia in the US and is a key component of Vytorin for treating hyperlipidemia. I have led teams of up to 24 chemists (including direct line supervision of 11 chemists) on multiple discovery projects, and maintained high productivity and morale of all team members. I have demonstrated strong team-building skills in interdisciplinary team interactions, and outstanding written and oral communication skills. My career goal is to provide leadership to multiple chemistry discovery teams to discover novel agents to treat human disease.
研究兴趣
论文共 121 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Xiaowen Peng,Christopher J. Holler, Anna -Maria F. Alves, Michelle G. Oliviera, Michael Speake, Angelo Pugliese, Mina R. Oskouei, Ivan D. de Freitas,Angela Y. -P. Chen, Richard Gallegos, Stephanie M. McTighe,Gerhard Koenig,Raymond S. Hurst,Jean-Francois Blain,James C. Lanter,Duane A. Burnett
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024): 129595-129595
Xiaowen Peng,James C. Lanter,Angela Y. -P. Chen,Morgan A. Brand, Mary K. Wozniak, Steven Hoekman, Ondrej Longin, Hendrik Regeling,Wim Zonneveld,Roel P. L. Bell,Gerhard Koenig,Raymond S. Hurst,Jean-Francois Blain,Duane A. Burnett
Alzheimer's & Dementiano. S10 (2022)
Burger's Medicinal Chemistry and Drug Discoverypp.1-36, (2021)
引用0浏览0引用
0
0
Hong Jin,Sudarshan Kapadnis,Ting Chen, Dooyoung Lee,Andrew McRiner, Andrew Cook,Duane A Burnett,Gerhard Koenig,Cuyue Tang
加载更多
作者统计
#Papers: 121
#Citation: 4759
H-Index: 31
G-Index: 66
Sociability: 6
Diversity: 2
Activity: 4
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn